Gonadotropin-releasing hormone antagonist linzagolix: possible treatment for assisted reproduction patients presenting with adenomyosis and endometriosis?

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Gonadotropin-releasing hormone antagonist linzagolix: possible treatment for assisted reproduction patients presenting with adenomyosis and endometriosis?
Like

Related Content

Fertility and Sterility
Fertility and Sterility Fertility and Sterility

Gonadotropin-releasing hormone antagonist linzagolix: possible treatment for assisted reproduction patients presenting with adenomyosis and endometriosis?

In a recent article, Donnez and Donnez (1) reported the use of the gonadotropin-releasing hormone (GnRH) antagonist linzagolix for the treatment of severe uterine adenomyosis.

VOLUME 114, ISSUE 3, P517-518

Authors:

Andrea Borini, M.D., Giovanni Coticchio, Ph.D.

Abstract:

Reflections on "GnRH antagonist (Linzagolix): a new therapy for uterine adenomyosis" by Donnez et al.

Read the full text here. 

 

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Recommended Content